Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Kidney Transplant Recipients (OPTI-TREX)

NCT05672550 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Pediatric Kidney Transplant Recipients

Interventions

DRUG: Bayesian based dose adjustment of enoxaparin
DRUG: Usual dose adjustment of enoxaparin

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]